Why the study?
Are plasma levels of tissue factor pathway inhibitor (TFPI) increased in patients with acute myocardial infarction compared to other thrombotic conditions and healthy volunteers?
Population
23 patients with acute myocardial infarction, 10 with pulmonary embolism, 10 with deep vein thrombosis, and…
Comparison
Percutaneous transluminal coronary angioplasty… vs Healthy volunteers, PE patients, and DVT patients
Design
Cohort
Follow-up
24 hours post-PTCA
Authors
Loading...
TFPI elevation associates with AMI versus other thromboses; leaves open its diagnostic or prognostic utility pending prospective validation.
Are plasma levels of tissue factor pathway inhibitor (TFPI) increased in patients with acute myocardial infarction compared to other thrombotic conditions and healthy volunteers?
TFPI levels are significantly elevated in AMI compared to other thrombotic conditions and transiently increase further following PTCA, suggesting release from ischemic tissues.
Kamikura et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: